Why CBD?
Patients Want Non-Opioid Recovery Options
Across aesthetic and surgical practices, post-operative patients increasingly ask about recovery options that are non-pharmaceutical and non-invasive. Many are cautious about opioids and prescription medications and prefer adjunct options that feel supportive rather than interventional.
CBD has become part of these conversations largely due to its non-intoxicating profile and its growing familiarity in wellness and recovery contexts. For patients, it represents a plant-derived option that aligns with a broader shift toward gentler, non-opioid approaches to post-procedure care.
This demand is not theoretical. LOM Solutions’ starting formulations are based on products that have been used continuously for more than three years in high-volume surgical practices, with repeat and expanding orders driven by patient interest over time.
Why CBD Is Used
CBD is commonly incorporated into wellness and recovery products because of its interaction with the body’s endocannabinoid system (ECS), a regulatory network involved in maintaining balance across multiple physiological processes.
Rather than acting as a blunt intervention, CBD is generally understood as supporting the body’s own regulatory mechanisms. This makes it appealing in post-operative contexts where practices seek adjunct options that feel measured, localized, and non-intoxicating.
When sourced and formulated responsibly, CBD is widely viewed as well-tolerated and suitable for professional and wellness-oriented environments. For practices, its role is not to replace established care protocols, but to acknowledge patient interest in non-pharmaceutical recovery support while remaining aligned with professional standards and compliance boundaries.
Reference Materials
The following resources are commonly cited in discussions around Cannabidiol (CBD) and its use in wellness and recovery contexts. These are provided for informational purposes and independent review.
Cannabis and Cannabidiol for Post-Operative Pain Management in Orthopedic Surgery: A Scoping Review
Source: Journal of Orthopaedic Surgery and Research
Year: 2025
Cannabidiol (CBD): A Systematic Review of Clinical and Preclinical Evidence in Pain Management
Source: Pharmaceuticals (MDPI)
Year: 2024
Topical Cannabidiol (CBD) for Scar Healing
Source: ClinicalTrials.gov
Year: 2023
Cannabidiol in Cutaneous Wound Healing: A Review
Source: International Journal of Molecular Sciences
Year: 2024
Cannabinoids and Wound Healing
Source: International Journal of Molecular Sciences
Year: 2024
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Source: Frontiers in Pharmacology
Year: 2022
The following references reflect documented shifts in patient preferences toward non-opioid, non-pharmaceutical recovery options, and growing consumer familiarity with CBD.
Prevalence and Motivations for Cannabidiol (CBD) Use in U.S. Adults
Source: Preventive Medicine Reports
Year: 2019
Cannabidiol Perceptions and Use in the Orthopaedic Patient Population
Source: Journal of Bone and Joint Surgery Open Access
Year: 2025
Cannabidiol Use in the United States: A Cross-Sectional Study
Source: Cannabis and Cannabinoid Research
Year: 2018
Most Americans Prefer to Try Non-Drug Pain Treatments First
Source: Gallup / Palmer College of Chiropractic (reported by TIME)
Year: 2017
Trends in Opioid Dispensing Among U.S. Surgeons
Source: JAMA Network Open
Year: 2024